Progyny, Inc.
PGNYHealthcareNASDAQHealthcare Plans · Last scanned May 29, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Progyny, Inc. focuses on Healthcare Plans services and products. Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. Valued at $2.01B, PGNY is a mid-cap name in its sector. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.
Market Cap
$2.01B
Beta
0.91
P/E (TTM)
32.94
P/E (Fwd)
11.64
EPS (TTM)
$0.78
EPS (Fwd)
$2.21
ROE
14.9%
ROA
9.1%
Cash
$225.1M
Total Debt
$27.3M
Free CF
$200.2M
52W Change
19.5%
Annual Financials
Cash vs Debt
With $225.1M in cash and $27.3M in debt, PGNY maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company generates $200.2M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 14.9% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 9.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $786.9M (2022) to $1.29B (2025), reflecting a 64% increase over the period.
With cash comfortably exceeding debt, PGNY has financial flexibility that may help navigate uncertain periods. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Progyny, Inc. and its sector.